Lv2
122 积分 2022-05-09 加入
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
4天前
已完结
The potential of B7-H6 as a therapeutic target in cancer immunotherapy
4天前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
12天前
已完结
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
12天前
已完结
Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET
23天前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
1个月前
已完结
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study
1个月前
已完结
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer
1个月前
已完结
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease
1个月前
已完结
皖公网安备34019202002308
